Skip to content
Nonprofiteer
← SANSUM DIABETES RESEARCH INSTITUTE

Form 990 for tax year 2025

Filed by SANSUM DIABETES RESEARCH INSTITUTE.

Totals

Total revenue
$6,303,337
Total expenses
$7,162,681
Contributions and grants received
$2,934,028
Grants paid
$0
Program service revenue
$2,087,229
Investment income
$1,412,044
Other revenue
-$129,964
Total assets, end of year
$28,805,606
Total liabilities, end of year
$4,051,624
Net assets or fund balances, end of year
$24,753,982
Program services expenses (Part IX)
$5,282,012
Management and general expenses
$1,034,974
Fundraising expenses
$845,695
Program service expenses (Part III)
$5,282,012

Program services were 73.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $465,074

  • 1f · All other contributions, gifts and grants

    $2,468,954

  • 1g · Noncash contributions included above

    $33,311

  • 2a · Program service revenue: Patient Care Fees

    total $50,045 · related or exempt $50,045

  • 2b · Program service revenue: Research Contracts

    total $2,037,184 · related or exempt $2,037,184

  • 3 · Investment income

    total $401,378 · excluded $401,378

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    securities $4,687,771

  • 7b · Less cost or other basis and sales expenses

    securities $3,620,847 · other assets $56,258

  • 7c · Gain or loss

    securities $1,066,924 · other assets -$56,258

  • 7d · Net gain or loss

    total $1,010,666 · related or exempt $1,010,666

  • 8a · Fundraising events: gross income

    $45,750

  • 8a · Fundraising events: contributions included on line 1c

    $465,074

  • 8b · Fundraising events: direct expenses

    $175,890

  • 8c · Net income from fundraising events

    total -$130,140 · excluded -$130,140

  • 9c · Net income from gaming

    total $0

  • 10c · Net income from sales of inventory

    total $0

  • 11a · Other revenue: Other

    total $176 · related or exempt $176

  • 11e · Other revenue, total

    $176

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $0

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $1,057,915 · program services $519,880 · management and general $255,955 · fundraising $282,080

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $3,267,323 · program services $2,871,992 · management and general $245,732 · fundraising $149,599

  • 8 · Pension plan contributions

    total $93,218 · program services $83,967 · management and general $7,258 · fundraising $1,993

  • 9 · Other employee benefits

    total $303,146 · program services $231,401 · management and general $49,550 · fundraising $22,195

  • 10 · Payroll taxes

    total $313,761 · program services $247,935 · management and general $35,042 · fundraising $30,784

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $9,434 · management and general $9,434

  • 11c · Fees: accounting

    total $27,000 · management and general $27,000

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $25,268 · management and general $25,268

  • 11g · Fees: other

    total $1,088,222 · program services $569,714 · management and general $290,537 · fundraising $227,971

  • 12 · Advertising and promotion

    total $34,415 · program services $6,372 · management and general $1,606 · fundraising $26,437

  • 13 · Office expenses

    total $98,086 · program services $63,072 · management and general $13,644 · fundraising $21,370

  • 14 · Information technology

    total $216,008 · program services $141,004 · management and general $30,112 · fundraising $44,892

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $35,864 · program services $26,009 · management and general $7,183 · fundraising $2,672

  • 17 · Travel

    total $24,137 · program services $17,917 · management and general $4,526 · fundraising $1,694

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $46,207 · program services $36,291 · management and general $4,627 · fundraising $5,289

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $161,832 · program services $133,121 · management and general $14,672 · fundraising $14,039

  • 23 · Insurance

    total $79,612 · program services $64,964 · management and general $12,828 · fundraising $1,820

  • 24a · Other expenses: Subject Reimbursement

    total $207,845 · program services $207,845

  • 24b · Other expenses: Lab Supplies

    total $55,770 · program services $55,770

  • 24c · Other expenses: Campaign Expenses

    total $17,618 · program services $4,758 · fundraising $12,860

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $496,358 · end of year $125,700

  • 2 · Savings and temporary cash investments

    beginning of year $7,773,243 · end of year $2,158,353

  • 3 · Pledges and grants receivable

    beginning of year $1,704,404 · end of year $1,679,962

  • 4 · Accounts receivable

    beginning of year $294,184 · end of year $262,369

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $600,000 · end of year $600,000

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $71,227 · end of year $51,175

  • 10a · Land, buildings and equipment: cost or other basis

    $11,403,191

  • 10b · Land, buildings and equipment: accumulated depreciation

    $2,016,487

  • 10c · Land, buildings and equipment, net

    beginning of year $2,134,330 · end of year $9,386,704

  • 11 · Investments: publicly traded securities

    beginning of year $9,857,957 · end of year $11,186,692

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    end of year $0

  • 15 · Other assets

    beginning of year $3,613,290 · end of year $3,354,651

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,078,731 · end of year $1,379,606

  • 23 · Secured mortgages and notes payable

    end of year $2,626,255

  • 25 · Other liabilities

    beginning of year $398,042 · end of year $45,763

  • 27 · Net assets without donor restrictions

    beginning of year $14,361,122 · end of year $13,399,618

  • 28 · Net assets with donor restrictions

    beginning of year $10,707,098 · end of year $11,354,364

Mission and programs · 2025

Mission

Dedicated to improving the lives of people impacted by diabetes through research, education and care.

  • ResearchClinical Research Type 1 DiabetesSansum Diabetes Research Institute (SDRI) is a nonprofit organization dedicated to improving the lives of people impacted by diabetes through clinical research, education, and specialized patient care. During 2025, SDRI initiated 13 clinical research trials involving 197 individual participants. These studies evaluated new technologies, medications, and treatment approaches intended to improve diabetes management and health outcomes.Research activities included automated insulin delivery systems, continuous glucose monitoring, inhaled insulin therapies, GLP-1 medications, ketone and lactate monitoring, digital health tools, and other emerging diabetes technologies. SDRI collaborated with leading diabetes technology and pharmaceutical companies to conduct research that supports the development of safer and more effective treatments for people living with diabetes.During 2025, SDRI also launched Screen & Support, a community-based type 1 diabetes early detection program. Through autoantibody screening, education, monitoring, and follow-up care, the program identifies children and adults at increased risk for developing type 1 diabetes before symptoms occur. Earlier identification helps reduce the likelihood of diagnosis during diabetic ketoacidosis (DKA), provides families with education and support, and expands access to therapies that may delay progression to insulin-dependent disease. SDRI also continued leading the California Type 1 Diabetes Screening Collaborative to expand early detection efforts throughout California.Clinical Research Type 2 DiabetesSDRI continued research designed to improve treatment options and clinical outcomes for individuals living with type 2 diabetes. During 2025, the SDRI participated in studies evaluating automated insulin delivery systems, continuous glucose monitoring technologies, and emerging therapeutic approaches intended to improve glycemic control while reducing the burden of diabetes management.Research findings contributed to the growing body of evidence supporting advanced diabetes technologies for adults with type 2 diabetes and included participation from diverse populations to improve the applicability of study findings across communities.

    Expenses $4,634,525 · Revenue $1,969,111

  • Education and Community OutreachCommunity education is an essential component of SDRI's charitable mission. SDRI provides evidence-based education, peer support, and culturally responsive programs that improve diabetes prevention and self-management.During 2025, SDRI continued Ocho Pasos a la Buena Salud, a Spanish-language diabetes prevention and self-management program led by trained Community Health Workers (Promotoras). The program provides culturally appropriate education on nutrition, physical activity, and diabetes self-management while addressing barriers to healthcare access.SDRI also expanded education and support through One Talk, LADA Talk, diabetes technology training, bilingual support groups, community outreach events, and Back-to-School educational programming. These programs improve diabetes knowledge, increase self-management skills, reduce diabetes-related distress, and strengthen community support for individuals and families affected by diabetes.

    Expenses $367,818 · Revenue $68,073

  • Clinical CareSDRI provides specialized outpatient clinical care in diabetes in pregnancy, pediatric diabetes, and adult endocrinology.During 2025, SDRI expanded its Diabetes in Pregnancy Program to preserve access to specialized care following changes in local maternal health services. SDRI assumed responsibility for caring for approximately 100 additional patients, with particular emphasis on serving under-resourced and underrepresented Latina women throughout Santa Barbara County.Clinical services include individualized diabetes management, nutrition counseling, continuous glucose monitoring support, medication management, diabetes education, and coordinated care with obstetric and maternal-fetal medicine providers. SDRI also provides culturally responsive and bilingual services to improve maternal and infant health outcomes.SDRI's pediatric diabetes program provides comprehensive education, technology training, behavioral support, and ongoing clinical care that helps children, adolescents, and families safely manage diabetes and successfully transition to lifelong self-management.

    Expenses $279,669 · Revenue $50,045

  • Research InfrastructureDuring 2025, SDRI completed renovation of its 18,000-square-foot research, clinical care, and education center. The renovated facility increased organizational capacity by providing dedicated research suites, expanded clinical space, industry collaboration areas, a teaching kitchen, a DEXA research suite, and community education facilities. These improvements enhance SDRI's ability to conduct clinical research, provide specialized patient care, and deliver diabetes education programs that benefit the community.Summary of Public BenefitThrough its integrated programs in clinical research, specialized clinical care, early detection, education, and community outreach, SDRI advances the early detection, treatment, and management of diabetes while improving access to evidence-based care for children, adults, pregnant individuals, and underserved populations. These activities further SDRIs charitable mission by improving health outcomes, expanding access to specialized services, and advancing diabetes science for the benefit of the public.

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Elizabeth Thompson

    CEO

    Total calculated
    $349,314
    From this org
    $329,755
    From related orgs
    $0
    Other
    $19,559
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $329,755
    Bonus
    not reported
    Other
    not reported
    Deferred
    $16,488
    Nontaxable benefits
    $3,071
    Filer's total
    $349,314
  • Kristin Castorino DO

    Research Physician

    Total calculated
    $290,760
    From this org
    $264,433
    From related orgs
    $0
    Other
    $26,327
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $264,433
    Bonus
    not reported
    Other
    not reported
    Deferred
    $13,520
    Nontaxable benefits
    $12,807
    Filer's total
    $290,760
  • Kristen Nelson

    Dir Clinical Rese

    Total calculated
    $270,167
    From this org
    $256,529
    From related orgs
    $0
    Other
    $13,638
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $256,529
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $13,638
    Filer's total
    $270,167
  • Dr Andrew Rhinehart

    CEO/CMO

    Total calculated
    $237,257
    From this org
    $230,465
    From related orgs
    $0
    Other
    $6,792
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $230,465
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $6,792
    Filer's total
    $237,257
  • Kara Hornbuckle

    VP Development and Public Affairs

    Total calculated
    $180,584
    From this org
    $168,763
    From related orgs
    $0
    Other
    $11,821
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $168,763
    Bonus
    not reported
    Other
    not reported
    Deferred
    $9,500
    Nontaxable benefits
    $2,321
    Filer's total
    $180,584
  • Sarintha Logan

    Clinical Research

    Total calculated
    $178,932
    From this org
    $161,001
    From related orgs
    $0
    Other
    $17,931
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $161,001
    Bonus
    not reported
    Other
    not reported
    Deferred
    $8,172
    Nontaxable benefits
    $9,759
    Filer's total
    $178,932
  • Trisha Purkey

    Clinical Research

    Total calculated
    $176,056
    From this org
    $156,913
    From related orgs
    $0
    Other
    $19,143
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $156,913
    Bonus
    not reported
    Other
    not reported
    Deferred
    $7,899
    Nontaxable benefits
    $11,244
    Filer's total
    $176,056
  • Melody Lung

    Clinical Research

    Total calculated
    $148,976
    From this org
    $136,826
    From related orgs
    $0
    Other
    $12,150
    Hours/week
    40
  • Olivia Watt

    Mgr Lab/Research

    Total calculated
    $139,105
    From this org
    $130,214
    From related orgs
    $0
    Other
    $8,891
    Hours/week
    40
  • James Sloan

    President

    Total calculated
    $0
    Hours/week
    4
  • Matthew Rowe CIMA

    Vice President

    Total calculated
    $0
    Hours/week
    2
  • Flint Ogle

    Treasurer

    Total calculated
    $0
    Hours/week
    2
  • Elena Engel

    Secretary

    Total calculated
    $0
    Hours/week
    2
  • Joan Doell Arnold

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Miguel Avila

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Daniel Berger MD

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Anthony Castillo

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Daren Dickerson

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Lindsey Duca PhD

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Lynn Fitzgibbons MD

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Yvette Giller

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Steven Jung Esq

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Norman Kurland

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Robert Nagy MD

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Michael Paskin

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Wendy Thies Sell

    Trustee

    Total calculated
    $0
    Hours/week
    1
  • Mark Wilson

    Trustee

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Written employment contract
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment

Answered no

  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2025
Filed
31 August 2026
IRS schema version
2025v4.1
Source object
202612439349300846

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.